Clinical Trials Browser

Phase 1 × Interventional × IT-101 × Clear all

NCT02648711 2020-05-28

Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumors

NCT01625936 2018-08-29

CRLX101 Plus Bevacizumab in Advanced RCC

Phase 1 Completed

Carcinoma, Renal Cell, Neoplasm Metastasis